TDP-43 pathology links innate and adaptive immunity in amyotrophic lateral sclerosis

  • bioRxiv. 2024 Jan 10:2024.01.07.574541. doi: 10.1101/2024.01.07.574541.
Baggio A Evangelista ,  Joey V Ragusa ,  Kyle Pellegrino ,  Yija Wu ,  Ivana Yoseli Quiroga-Barber ,  Shannon R Cahalan ,  Omeed K Arooji ,  Jillann A Madren ,  Sally Schroeter ,  Joe Cozzarin ,  Ling Xie ,  Xian Chen ,  Kristen K White ,  J Ashley Ezzell ,  Marie A Iannone ,  Sarah Cohen ,  Rebecca E Traub ,  Xiaoyan Li ,  Richard Bedlack ,  Douglas H Phanstiel ,  Rick Meeker ,  Natalie Stanley ,  Todd J Cohen
Abstract

Amyotrophic Lateral Sclerosis is the most common fatal motor neuron disease. Approximately 90% of ALS patients exhibit pathology of the master RNA regulator, Transactive Response DNA Binding protein (TDP-43). Despite the prevalence TDP-43 pathology in ALS motor neurons, recent findings suggest immune dysfunction is a determinant of disease progression in patients. Whether TDP-43 pathology elicits disease-modifying immune responses in ALS remains underexplored. In this study, we demonstrate that TDP-43 pathology is internalized by antigen presenting cells, causes vesicle rupture, and leads to innate and adaptive immune cell activation. Using a multiplex imaging platform, we observed interactions between innate and adaptive immune cells near TDP-43 pathological lesions in ALS brain. We used a mass cytometry-based whole-blood stimulation assay to provide evidence that ALS patient peripheral immune cells exhibit responses to TDP-43 aggregates. Taken together, this study provides a novel link between TDP-43 pathology and ALS immune dysfunction, and further highlights the translational and diagnostic implications of monitoring and manipulating the ALS immune response.

Products